Legal Representation
Attorney
Karl M. Zielaznicki, Esq.
USPTO Deadlines
Next Deadline
1979 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-17)
Due Date
December 17, 2030
Grace Period Ends
June 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 17, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 17, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 15, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 15, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 6, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 4, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 3, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 21, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 21, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 21, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 31, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 31, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jan 26, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical devices used for administering pharmaceutical preparations for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting pharmaceutical preparations for use in treating or diagnosing disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting and administering pharmaceutical preparations. for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders
First Use Anywhere:
Jan 1, 2020
First Use in Commerce:
Jan 1, 2020
Additional Information
Design Mark
The mark consists of the word "TAKEDA" in stylized lettering, appearing inside of two intersecting arcs, the lower arc with a straight line on the bottom and the higher arc being thicker in size and with two sides extending over the lower arc.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
010